IL235030A0 - 6- Transmuted amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators - Google Patents

6- Transmuted amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators

Info

Publication number
IL235030A0
IL235030A0 IL235030A IL23503014A IL235030A0 IL 235030 A0 IL235030 A0 IL 235030A0 IL 235030 A IL235030 A IL 235030A IL 23503014 A IL23503014 A IL 23503014A IL 235030 A0 IL235030 A0 IL 235030A0
Authority
IL
Israel
Prior art keywords
nicotinamides
kcnq2
modulators
amino
substituted
Prior art date
Application number
IL235030A
Other languages
English (en)
Hebrew (he)
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of IL235030A0 publication Critical patent/IL235030A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
IL235030A 2012-04-18 2014-10-07 6- Transmuted amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators IL235030A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12002709 2012-04-18
PCT/EP2013/001134 WO2013156154A1 (en) 2012-04-18 2013-04-17 Substituted 6-amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators

Publications (1)

Publication Number Publication Date
IL235030A0 true IL235030A0 (en) 2014-12-31

Family

ID=48227140

Family Applications (1)

Application Number Title Priority Date Filing Date
IL235030A IL235030A0 (en) 2012-04-18 2014-10-07 6- Transmuted amino-nicotinamides bearing an oh-containing group as kcnq2/3 modulators

Country Status (21)

Country Link
EP (1) EP2888233B1 (enExample)
JP (1) JP6033403B2 (enExample)
CN (1) CN104428287A (enExample)
AR (1) AR090739A1 (enExample)
AU (1) AU2013248637A1 (enExample)
BR (1) BR112014025840A2 (enExample)
CA (1) CA2870573A1 (enExample)
CY (1) CY1118255T1 (enExample)
DK (1) DK2888233T3 (enExample)
EA (1) EA201401142A1 (enExample)
ES (1) ES2605947T3 (enExample)
HK (1) HK1210173A1 (enExample)
HR (1) HRP20161424T1 (enExample)
HU (1) HUE030859T2 (enExample)
IL (1) IL235030A0 (enExample)
LT (1) LT2888233T (enExample)
MX (1) MX2014012494A (enExample)
PT (1) PT2888233T (enExample)
RS (1) RS55466B1 (enExample)
SI (1) SI2888233T1 (enExample)
WO (1) WO2013156154A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3447047A1 (en) * 2016-04-22 2019-02-27 ONO Pharmaceutical Co., Ltd. Crystal polymorphism of kcnq 2-5 channel activator
WO2019130185A1 (en) * 2017-12-29 2019-07-04 3M Innovative Properties Company Thermally curable two part processing adhesive composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2230392A1 (de) 1972-06-22 1974-01-31 Cassella Farbwerke Mainkur Ag Substituierte pyridinverbindungen und verfahren zu ihrer herstellung
DE2513949A1 (de) 1975-03-29 1976-10-07 Bayer Ag Azofarbstoffe
CZ20032233A3 (cs) 2001-02-20 2004-12-15 Bristol-Myers Squibb Company Derivát 2,4-disubstituovaného pyrimidin-5-karboxamidu jako modulátor draslíkového kanálku KCNQ
MXPA03007397A (es) 2001-02-20 2003-12-04 Bristol Myers Squibb Co Moduladores de canales de potasio kcnq y uso de los mismos en tratamiento de migrana y enfermedades mecanicamente relacionadas.
EP2086935A1 (de) * 2006-10-16 2009-08-12 Grünenthal GmbH Substituierte sulfonamid-derivate als bradykinin 1 rezeptor modulatoren
DE102006049452A1 (de) 2006-10-17 2008-05-08 Grünenthal GmbH Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln
JP2012506395A (ja) 2008-10-24 2012-03-15 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 痛み、てんかん、及び尿失禁の治療のためのkcnq2/3モジュレーターとしての置換された4,5,6,7−テトラヒドロチエノピリジン
TWI475020B (zh) * 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
CA2815131C (en) * 2010-10-20 2020-06-09 Gruenenthal Gmbh Substituted 6-amino-nicotinamides as kcnq2/3 modulators

Also Published As

Publication number Publication date
WO2013156154A1 (en) 2013-10-24
EP2888233B1 (en) 2016-09-28
AR090739A1 (es) 2014-12-03
CN104428287A (zh) 2015-03-18
AU2013248637A1 (en) 2014-12-04
BR112014025840A2 (pt) 2017-07-18
CA2870573A1 (en) 2013-10-24
JP2015514728A (ja) 2015-05-21
JP6033403B2 (ja) 2016-11-30
EA201401142A1 (ru) 2015-03-31
CY1118255T1 (el) 2017-06-28
HRP20161424T1 (hr) 2016-12-16
HK1210173A1 (en) 2016-04-15
DK2888233T3 (en) 2017-01-09
SI2888233T1 (sl) 2016-12-30
HUE030859T2 (en) 2017-06-28
EP2888233A1 (en) 2015-07-01
PT2888233T (pt) 2017-01-04
MX2014012494A (es) 2015-01-15
ES2605947T3 (es) 2017-03-17
RS55466B1 (sr) 2017-04-28
LT2888233T (lt) 2017-01-10

Similar Documents

Publication Publication Date Title
IL225762A0 (en) 6- amino-nicotinamides are converted as 2/3 kcnq modulators
PL2669546T3 (pl) Układ smarowania łożysk
EP3048318A4 (en) Bearing structure
EP2711573B8 (en) Bearing device
EP2815141A4 (en) BEARING COMPONENT
PL2906844T3 (pl) Zespół łożyskowy
GB2500487B (en) Tribological coating
ZA201302266B (en) Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators
GB2498460B (en) Bearing retainer
PL2871998T3 (pl) System nośny
GB201220163D0 (en) Sliding bearing
ZA201302265B (en) Substituted 2-oxo-and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators
GB201223351D0 (en) Sliding bearing
GB201223322D0 (en) Sliding bearing
PT2888233T (pt) 6-aminonicotinamidas substituídas portadoras de um grupo contendo oh como moduladores de kcnq2/3
GB201201498D0 (en) Bearing assembly
GB201112650D0 (en) Bearing preset system
GB2523499B (en) All-graphite interferometer bearing assembly
EP3045753A4 (en) Bearing structure
EP2906843A4 (en) BALL SOCKET
TWM432338U (en) M1010701_3919
HUP1200408A2 (hu) Eljárás magas fordulatú sikló, gördülõ és hibrid csapágyak elõállítására
AU2012900398A0 (en) Point 10
GB201218590D0 (en) 1225 system
AU2012904837A0 (en) The macwell 100 group